Peritoneal Dialysis in Acute Renal and Liver Failure  by Viţălaru, Bogdan Alexandru & Micşa, Cătălin
 Agriculture and Agricultural Science Procedia  6 ( 2015 )  392 – 396 
2210-7843 © 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Peer-review under responsibility of the University of Agronomic Sciences and Veterinary Medicine Bucharest
doi: 10.1016/j.aaspro.2015.08.104 
Available online at www.sciencedirect.com
ScienceDirect
“ST26733”, International Conference "Agriculture for Life, Life for Agriculture" 
Peritoneal dialysis in acute renal and liver failure 
Bogdan Alexandru ViĠălaru, Cătălin Micúaa* 
aUniversity of Agronomic Sciences and Veterinary Medicine of Bucharest, 59 Mărăúti Blvd, District 1, 011464, Bucharest, Romania 
Abstract 
A 11-year-old 3.1 kg, castrated, female Sphinx cat was referred to the Clinic of the Faculty of Veterinary Medicine Bucharest for 
acute onset vomiting, loss of appetite, anorexia, faintness, sharp breath, inability to exercise, oliguria and lethargy. Results from a 
complete blood (cell) count (CBC), serum chemical profile, and urinalysis submitted at that time were abnormal. The patient had 
hyperglycaemia (Glu-164mg/dl), acute renal failure (Crea-3.4mg/dl, BUN-117mg/dl) and acute liver failure (ALT-744U/L, 
TBIL-11.8mg/dl). The ALKP was 155U/L. The rectal temperature was 37,4ºC, the patient presented anaemic mucous 
membranes, mild dehydration (persistent skin fold thickness 2-3 seconds) and slight sensitivity to palpation in the renal lanyard. 
The established treatment consisted in peritoneal dialysis, rehydration and electrolyte balance, parenteral nutrition. We used PD4 
peritoneal dialysis Dianeal 200 ml (1000ml / sqm). The patient was submitted to intravenous fluidotherapy with 5% Dextrose, 
Sodium Chloride 0.9 %, Aspatofort, Ondansetron, Metoclopramide and Duphalyte, CRI for 18 days. Abdominal ultrasound 
showed bile duct obstruction, abundant sludge in the gallbladder and mild modification in kidneys. Recommendation for oral 
treatment: Ipakitine bid, Azodyl bid and kidney diet food. The patient started to eat voluntary after 8 days of treatment. TBIL 
went up to 23.3mg/ml after the first 7 days and then started to decrease until it reached 0.9mg/dl at the end of the parenteral 
treatment. BUN and Creatinine values decreased to normal after the first 7 days of peritoneal dialysis and parenteral treatment. 
Peritoneal dialysis therapy plays an important role in renal failure in cats, especially in the elderly and weighing up to 10 kg. 
Elevated levels of creatinine and urea, hyperkalemia, hyper phosphatemia, or metabolic acidosis which do not yield to treatment 
can be solved using peritoneal dialysis. It also has a good effect in acute liver failure, cleaning the high levels of bilirubine. 
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1. Introduction 
 
Peritoneal dialysis is a technique whereby infusion of dialysis solution into the peritoneal cavity is followed by 
a variable dwell time and subsequent drainage. During peritoneal dialysis, solutes and fluids are exchanged between 
the capillary blood and the intraperitoneal fluid through a biologic membrane, the peritoneum. Inadequate renal 
function leads to disturbance in the removal of the extra fluid and waste products. It removes the waste product and 
extra fluid from the body in renal failure in small animal practice. Peritoneal dialysis is more accessible, more 
affordable and easier to administer to the small animal patient. The most common indication for peritoneal dialysis 
in cats is acute renal failure (ARF). Peritoneal dialysis is an important therapeutic tool for mitigating clinical signs 
of uraemia and giving the kidneys time to recover in cats with acute kidney injury when conventional therapy is no 
longer effective (Bhatt et al., 2011). 
Peritoneal dialysis is a modality of renal replacement therapy that is commonly used in human medicine for 
treatment of chronic kidney disease and end-stage kidney failure. Peritoneal dialysis uses the peritoneum as a 
membrane across which fluids and uremic solutes are exchanged. In this process, dialysate is instilled into the 
peritoneal cavity and, through the process of diffusion and osmosis, water, toxins, electrolytes, and other small 
molecules, allowed to equilibrate (Cooper and Labato, 2011). 
Peritoneal dialysis uses the peritoneum as a semi permeable layer for dialysis in which excess water, ions and 
solute in the blood pass through a semi permeable membrane to a sterile solution which is known as dialysate via 
diffusion, osmosis and filtration. The three-layered peritoneal membrane consists of 1) themesothelium, a 
continuousmonolayer of flat cells, and their basement membranes; 2) a very compliant interstitium; and 3) the 
capillary wall, consisting of a continuous layer of mainly non-fenestrated endothelial cells, supported by a basement 
membrane. The mesothelial layer is considered to be less of a transport barrier to fluid and solutes, including 
macromolecules, than is the endothelial layer (Clough and Michel, 1988). Solute transport rates are assessed by the 
rates of their equilibration between the peritoneal capillary blood and dialysate. The ratio of solute concentrations in 
dialysate and plasma at specific times during the dwell signifies the extent of solute transport. Creatinine and urea 
clearance rates are the most commonly used indices of dialysis adequacy in clinical settings. Contributions of 
residual renal clearances are significant in determining the adequacy of dialysis (Flessner et al., 1985). 
 
2. Research Methods 
An 11-year-old, 3.1 kg, castrated, female Sphinx cat was referred on November the 10th 2014 to the Clinic of 
the Faculty of Veterinary Medicine Bucharest for acute onset vomiting, loss of appetite, anorexia, faintness, sharp 
breath, inability to exercise, oliguria and lethargy. The physical examination revealed that the patient was anorexic, 
lethargic, had inability to exercise and a pronounced yellowish colour of skin and mucosa. Results from a complete 
blood cell count (CBC), serum chemical profile, and urinalysis submitted at that time were abnormal. The rectal 
temperature was 37.4ºC the patient presented slight sensitivity to palpation in the renal lanyard. Abdominal 
ultrasound showed mild modification in kidneys. The established treatment consisted in peritoneal dialysis, 
rehydration and electrolyte balance, parenteral nutrition. The patient was also submitted to intravenous fluidotherapy 
with 5% Dextrose, Sodium Chloride 0.9%, Aspatofort, Ondansetron, Metoclopramide and Duphalyte, CRI 
(Kushwaha and Singh, 2008). 
 
3. Results and discussion 
The patient was presented with abnormal blood biochemistry values in the first day. The patient had 
hyperglycemia - Glucose - 164 mg/dl (reference range 71-159 mg/dL), acute renal failure (Creatinine - 3.4 mg/dl - 
reference range 0.8-2.4 mg/dL, BUN - 117 mg/dl - reference range 16-36 mg/dL) and acute liver failure (ALT - 744 
U/L - reference range 12-130 U/L, TBIL - 11.8 mg/dl - reference range 0.0-0.9 mg/dL). The ALKP was 155 U/L - 
reference range 14-111 U/L. The rectal temperature was 37.4ºC, the patient presented yellow anaemic mucous 
membranes, mild dehydration (persistent skin fold thickness 2-3 seconds) and slight sensitivity to palpation in the 
renal lanyard. 
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Abdominal ultrasound showed mild modification in kidneys. Recommendation for oral treatment: Ipakitine bid, 
Azodyl bid and kidney diet food. 
The established treatment consisted in peritoneal dialysis, rehydration and electrolyte balance, parenteral 
nutrition. We used PD4 peritoneal dialysis Dianeal 200 ml (1000 ml/sqm) after placing the peritoneal catheter and 
after we managed to accommodate the patient with the peritoneal distension. Aseptic technique is imperative for the 
peritoneal dialysis (the use of surgical scrub and sterile surgical technique during catheter placement, as well as the 
use of sterile gloves, disinfectants, and the careful handling of dialysate fluids, catheters, and catheter line during 
dialysis), (Thornhill, 1981). The catheter enters the abdomen on midline at the level of the umbilicus and it is 
directed caudally and positioned in the lower pelvis (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Latero-ventral aspect of the patient’s abdomen with the placement of the catheter 
The patient was also submitted to intravenous fluidotherapy with 5% Dextrose, Sodium Chloride 0.9%, 
Aspatofort, Ondansetron, Metoclopramide and Duphalyte, CRI. 
On 11th of November 2014, the first day of treatment, the patient was presented with 37.5°C body temperature 
and we started administrating fluidotherapy IV in a volume set at 30 ml per hour twice a day: Dextrose 5% 15 ml, 
Sodium Chloride 0.9% 30 ml, Aspatofort 1 ml and subcutaneous Emeset 0.4 ml. Peritoneal dialysis was performed 
infusing 200 ml Dianeal PD4 (1000 ml/sqm) and we collected 130 ml after 4 hours of dwelling. 
On the next two days we used the same protocol of peritoneal dialysis and we managed to recover this time 
160-180 ml after 4 hours. The fluidotherapy remained the same, 30 ml/h and the temperature dropped at 37°C. On 
the 13th of November the blood tests showed: Glu 196 mg/dL (reference range 71-159 mg/dL), BUN decreased to 73 
mg/dL (reference range 16-36 mg/dL), and the creatinine decreased at a normal value of 1.6 mg/dL (reference range 
0.8-2.4 mg/dL). The transaminaze ALT and ALKP also decreased: ALT 509 U/L (reference range 12-130 U/L), 
ALKP 121 U/L (reference range 14-111 U/L) but the total bilirubin (TBIL) increased at 18.4 mg/dL (reference 
range 0.0-0.9 mg/dL). The pancreatic lipase dropped at 59 U/L (reference range 100-1400 U/L). 
On November the 14th, the patient presented hyperthermia (40.2°C) and we performed a second abdominal 
ultrasound exam where we noticed the bile duct obstruction and abundant sludge in the gallbladder. The IV 
fluidotherapy was modified to: Dextrose 10% 7.5 ml, Sodium Chloride 0.9% 50 ml, Aspatofort 2 ml, Duphalyte 15 
ml and Metoclopramide 0.3 ml twice a day. The same protocol of peritoneal dialysis have been used and we 
managed to recover 160-180 ml after 4 hours. We followed the same treatment for the next two days and the 
temperature decreased at 39.2°C. On the 16th of November we performed a complete blood count which shown 
granulocytosis and thrombocytosis which indicated mostly an infection corroborated with a kidney disease. The 
following days the temperature dropped at 38.4°C and we administered, at a constant-rate of infusion of 20 ml per 
hour for 12 hours per day, Dextrose 10% 30 ml, Sodium Chloride 0.9% 200 ml, Aspatofort 8 ml, Duphalyte 15 ml 
and Metoclopramide 2 ml (Figure 2). 
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Figure 2. Latero-ventral aspect of the patient’s abdomen with the placement of the catheter and the administration 
of the peritoneal dialysis solution 
 
On the 18th we run biochemistry blood tests and the results were quite remarkable: BUN, creatinine and glucose 
came back to normal reference rates. Glu 120 mg/dL (reference range 71-159 mg/dL), BUN decreased to 33 mg/dL 
(reference range 16-36 mg/dL), and the creatinine maintained at a normal value of 2.0 mg/dL (reference range 0.8-
2.4 mg/dL). The only parameters which remain high were ALT, TBIL and GGT. ALT was 469 U/L (reference range 
12-130 U/L), TBIL decreased to 5.8 mg/dL (reference range 0.0-0.9 mg/dL) and GGT decreased to 10 U/L 
(referance range 0-1 U/L). The same protocols of peritoneal dialysis have been used and we managed to recover 180 
ml after 4 hours. 
We followed the same treatment for the next four days and the temperature went back to a normal value of 
38.4°C. On the 21st of November we run biochemistry blood tests and the ALT decreased to 387 U/L (reference 
range 12-130 U/L), TBIL decreased to 3.5 mg/dL (reference range 0.0-0.9 mg/dL) and GGT decreased to 8 U/L 
(reference range 0-1 U/L). The same protocols of peritoneal dialysis have been used and we managed to recover 180 
ml after 4 hours. On the 21st of November, our patient presented appetite for the first time and eat voluntary. From 
this moment it started to eat every two hours renal diet and drink by herself. We decided to stop the peritoneal 
dialysis, the peritoneal catheter was removed and dialysis was discontinued. The patient's condition has improved 
significantly (Table 1). 
 
Table 1. The evolution of blood biochemistry values during the treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
We followed the same venous treatment for the next seven days and the temperature maintained at a normal 
value of 38.4°C. On the 28th of November we run biochemistry blood tests and BUN was 46 mg/dL (reference range 
16-36 mg/dL) and all the other parameters maintained in normal ranges of value. The patient's condition has 
improved significantly.We decided to discontinue the venous treatment and we recommended oral treatment: 
Ipakitine bid, Azodyl bid and kidney diet food. 
In comparison with the literature, the decrease in BUN and creatinine were quite remarkable, the BUN 
decreasing from 117 mg/dL to 33 mg/dL in eight days and the Creatinine from 3.4 mg/dL to 1.6 mg/dL in three days. 
Parameter 10.11 13.11 18.11 21.11 28.11 
Glucose 
(71-159 mg/dL) 164 196 120 129 94 
BUN 
(16-36 mg/dL) 117 73 33 34 46 
Creatinine 
(0.8-2.4 mg/dL) 3.4 1.6 2.0 1.7 1.4 
ALT 
(12-130 U/L) 744 509 469 367 109 
GGT 
(0-1 U/L) 0 15 10 8 0 
TBIL 
(0.0-0.9 mg/dL) 11.8 18.4 5.8 3.5 0.9 
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We had also great results with total bilirubine, TBIL decreasing from 18.4 mg/dL to 0.9 mg/dL in 15 days 
(Stojimirovici and Trbojevic-Stankovic, 2007). 
 
4. Conclusions 
Peritoneal dialysis therapy plays an important role in renal failure in cats, especially in the elderly and weighing 
up to 10 kg. Elevated levels of creatinine and urea, hyperkalemia, hyper phosphatemia, or metabolic acidosis which 
do not yield to treatment can be solved using peritoneal dialysis. It also has a good effect in acute liver failure, 
cleaning the high levels of bilirubine. 
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